Physician profile
Shelley Street Callender
NPI 1184773939
$404.33
in general payments reported to CMS, 2019-2025
9 companies · $40.40 in 2025
The $40.40 reported for 2025 was less than what a typical Sports Medicine (Pediatrics) provider received nationally (typical 2025 total: $59.86).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.18 · 2020: $63.83 · 2021: $46.13 · 2022: $169 · 2025: $40.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $40.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $40.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $134.17 | 2022 | |
| Merck Sharp & Dohme LLC | $85.52 | 2019-2022 | |
| Team 1, LLC | $40.40 | 2025 | |
| Glaxosmithkline, LLC. | $39.26 | 2021-2022 | |
| Pfizer INC. | $26.63 | 2019-2021 | |
| Depuy Synthes Sales INC. | $23.36 | 2019 | |
| Ironshore Pharmaceuticals INC. | $21.03 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.02 | 2020 | |
| Mylan Pharmaceuticals INC. | $14.94 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelley Callender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.